IFATS Conference 2016 summary: Fat Grafts, adipose stem cells, and the big picture

IFATS 2016 conference in San Diego

As some of you who read this blog regularly already know, I am a huge proponent of fat grafting and the therapeutic applications of adipose stem cells.

Ever since 2009 I have been writing about the regenerative properties of fat grafts and stem cells. After joining IFATS, the International Federation for Adipose Therapeutics and Science, an organization devoted to the study of adipose tissue, I have become increasingly more involved.

In 2013 I was awarded a Maryland Stem Cell Grant to study the use of adipose stem cells to heal breast tissue damaged by radiation. Last year I was elected President of IFATS, and tomorrow I will be presiding over the 14th annual conference in San Diego. I am extremely excited about all that we have planned. Over 160 abstracts will be presented and they are all fabulous! Here is a bit of an overview about what is planned for the 2016 IFATS meeting.

IFATS 2016: San Diego, California

IFATS Conference Program 2016

We’ll be kicking off this year’s IFATS meeting with an exciting morning dedicated to ‘Fat graft process engineering’. Later we will focus on the therapeutic applications of adipose stem cells. We’re bringing together not only the leading clinical practitioners, but also leading endocrinologists, experts in the field of genomics and big data as applied to medicine, and stem cell researchers from other specialties such as cardiology and orthopedics.

Dr. Carlos Isales and Dr. Sydney Coleman
Dr. Carolos Isales and Dr. Sydney Coleman

Keynote speakers include Sydney Coleman, MD, who will be speaking about The Process of Fat grafting and Carlos M. Isales, MD, who will be speaking about Bone, fat and aging: therapeutic options.

We will also be welcoming speakers who will be focused on big data and machine learning in Medicine. This includes a keynote by Google’s director of software engineering, Philip Nelson, who will present applications of machine learning in medicine.

Don’t miss this rare opportunity to get “the big picture” about fat grafting, from the bench to clinical uses and beyond to the possibilities of applying “big data” techniques to our growing knowledge.

“Don’t miss this rare opportunity to get the Big Picture about fat grafting”

-Dr. Rodriguez

The IFATS program will involve the presentation of over 160 abstracts on a wide range of fat grafting and adipose stem cell topics affecting researchers, clinicians, the biotech industry, and patients.

Keynote and guest speakers include

  • The Role of Genomics complementing Cell Based Therapy
    Dietrich Stephan, PhD – Professor and Chair of the Department of Human Genetics at the University of Pittsburgh Graduate School of Public Health
  • Bone, Fat, Aging- Explaining Fat’s therapeutic role in Medicine and Aging
    Carlos Isales, MD, Professor of Neuroscience and Regenerative Medicine at Augusta University
  • Machine Learning in Clinical Medicine
    Philip Nelson, Director of Software Engineering, lead of translational research team at Google, focusing on applications of machine learning in Medicine
  • Adipose Derived Stromal Cells for soft and hard tissue clinical needs
    Michael Longaker MD, co-director of Institute for Stem Cell Biology and Regenerative Medicine at Stanford University

Presentation topics include

  • Fat graft process engineering
  • Industry showcase of companies involved in fat graft/stem cell processing
  • Adipose stem cell biology, characterization, and isolation techniques
  • Safety and efficacy of ASCs in breast reconstruction
  • Antibacterial affects of Adipose Stem Cells
  • Using ultrasounds and machine learning techniques
  • FDA and regulatory issues with adipose stem cells
  • Pilot studies and therapeutic applications using adipose fat and stem cells in treatment of:
    • osteoarthritis
    • exercise induced pulmonary hemorrhage
    • radiation damage
    • migranes
    • acne and scars
    • burns
    • organ transplants
    • myocardial ischemia
    • flap survival
    • HIV therapy
    • Parry-Romberg syndrome
    • gluteal augmentation

Clinical trial updates include

Updates on human and animal clinical trials using SVF and adipose stem cells for the following indications will be featured on Friday and Saturday sessions:

  • hair loss and alopecia
  • wrist arthritis
  • erectile dysfunction
  • urinary incontinence
  • crohn’s disease
  • facial atrophy in HIV
A list of IFATS speakers and moderators.

You can find the entire program on the IFATS website.

More about IFATS

IFATS logo

Founded in 2003, IFATS is a non-profit scientific society that promotes the exchange of information among researches and is currently the world’s only interdisciplinary fat tissue society. Committed to serving as the premier global incubator in the field of fat applied technology, current scientific areas of interest relate to facilitating the development of treatments for excess body fat, the generation of new fat tissue for reconstruction after cancer or birth-related defects and the use of adipose tissue as a source of mesenchymal stem cells that have the potential to regenerate and repair different body tissues. Learn more at IFATS.org.

(Article originally published November 16, 2016)

By Dr. Ricardo L. Rodriguez MD Board Certified Plastic Surgeon Cosmeticsurg Baltimore, Maryland Ricardo L. Rodriguez on American Society of Plastic Surgeons.

Related categories

Leave a Reply

Your email address will not be published. Required fields are marked *

4 thoughts on “IFATS Conference 2016 summary: Fat Grafts, adipose stem cells, and the big picture”

  • John Liposky says:

    What 21st Century Cures Act or other fast track Clinical Trials (Phase & 4) are being done or in the works for adipose Stem Cell treatment. Paracrine effect is obviously the process that effects regeneration of organ tissue. 70 million Americans suffer from arthritis so this should be primary target of research There is no dearth of phase 1 & 2 clinical trials proving safety and efficacy so what is holding up large trials that would provide dosage and delivery guidelines. Is your organization promoting this research, if so, how?
    • Dr. Ricardo L Rodriguez says:

      We are involved at several levels.To do things within the legal framework is expensive and time consuming. The first is drafting of standards for adipose tissue processing facilities. This is so there is a control over providers to protect the consumer against unscrupulous snake oil salespeople and ensure product quality. The second is using the new expedited pathways set up by the FDA. This includes creation of a National Stem Cell Registry to keep track of results of therapy. It also includes creation of protocols designed for multi center trials to get the therapies out to as many centers as possible. As for promoting the research, the society has an annual meeting for presentation of research results. It does not have money to fund research.
  • Yvonne sanders says:

    I'd like to know whether you do fat tranfer for the breast and what is the cost. And a bbl and cost. If someone comes where do they stay to do the surgery and after the surgery.
    • Dr. Ricardo L Rodriguez says:

      Yvonne, I am sorry we have not gotten back to you. I do not use this blog for patient contacts. The person to get in contact with is Leeza, at leeza@cosmeticsurg.net and I have given her your address. Thanks for your interest!